Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID Reference, 5th edition, 486 pages

Free download


  Diseases of the Thyroid

  Free Subscription


Articles published in Cancer

Retrieve available abstracts of 56 articles:
HTML format



Single Articles


    April 2020
  1. PRINTZ C
    Radiation from computed tomography scans is associated with increased risk for thyroid cancer and leukemia.
    Cancer. 2020;126:1601.
    PubMed    


    December 2019
  2. CHEN DW, Reyes-Gastelum D, Wallner LP, Papaleontiou M, et al
    Disparities in risk perception of thyroid cancer recurrence and death.
    Cancer. 2019 Dec 23. doi: 10.1002/cncr.32670.
    PubMed     Abstract available


    October 2019
  3. FAN D, Ma J, Bell AC, Groen AH, et al
    Outcomes of multimodal therapy in a large series of patients with anaplastic thyroid cancer.
    Cancer. 2019 Oct 8. doi: 10.1002/cncr.32548.
    PubMed     Abstract available


  4. PRINTZ C
    First person profile: Albert de la Chapelle, MD, PhD: Known for several pioneering discoveries in genetics, Dr. de la Chapelle is working to shed light on the genes that cause thyroid cancer.
    Cancer. 2019;125:3285-3286.
    PubMed    


    July 2019
  5. BERNIER MO, Kitahara CM, Shiels MS
    Reply to Natural history of thyroid cancer suggests beginning of the overdiagnosis of juvenile thyroid cancer in the United States and Harm of overdiagnosis or extremely early diagnosis behind trends in pediatric thyroid cancer.
    Cancer. 2019 Jul 29. doi: 10.1002/cncr.32425.
    PubMed    


  6. MIDORIKAWA S, Murakami M, Ohtsuru A
    Harm of overdiagnosis or extremely early diagnosis behind trends in pediatric thyroid cancer.
    Cancer. 2019 Jul 29. doi: 10.1002/cncr.32426.
    PubMed    


  7. TAKANO T
    Natural history of thyroid cancer suggests beginning of the overdiagnosis of juvenile thyroid cancer in the United States.
    Cancer. 2019 Jul 29. doi: 10.1002/cncr.32424.
    PubMed    


    June 2019
  8. KIM M, Kim BH, Kim JM, Kim EH, et al
    Concordance in postsurgical radioactive iodine therapy recommendations between Watson for Oncology and clinical practice in patients with differentiated thyroid carcinoma.
    Cancer. 2019 Jun 19. doi: 10.1002/cncr.32166.
    PubMed     Abstract available


  9. SHERMAN EJ, Dunn LA, Schoder H, Ho AL, et al
    Phase 2 study of vascular endothelial growth factor trap for the treatment of metastatic thyroid cancer.
    Cancer. 2019 Jun 7. doi: 10.1002/cncr.32046.
    PubMed     Abstract available


    April 2019
  10. BERNIER MO, Withrow DR, Berrington de Gonzalez A, Lam CJK, et al
    Trends in pediatric thyroid cancer incidence in the United States, 1998-2013.
    Cancer. 2019 Apr 23. doi: 10.1002/cncr.32125.
    PubMed     Abstract available


  11. GOLDENBERG D
    We cannot ignore the real component of the rise in thyroid cancer incidence.
    Cancer. 2019 Apr 23. doi: 10.1002/cncr.32123.
    PubMed    


  12. CHEN AY, Davies L
    Children and thyroid cancer: Interpreting troubling trends.
    Cancer. 2019 Apr 23. doi: 10.1002/cncr.32124.
    PubMed    


    January 2019
  13. DING DC, Chen W, Wang JH, Lin SZ, et al
    Thyroid cancer risk in women with infertility and association with fertility medications in Taiwan.
    Cancer. 2019 Jan 15. doi: 10.1002/cncr.31964.
    PubMed     Abstract available


    April 2018
  14. WIRTH LJ, Tahara M, Robinson B, Francis S, et al
    Treatment-emergent hypertension and efficacy in the phase 3 Study of (E7080) lenvatinib in differentiated cancer of the thyroid (SELECT).
    Cancer. 2018 Apr 14. doi: 10.1002/cncr.31344.
    PubMed     Abstract available


    February 2018
  15. ROCHE AM, Fedewa SA, Shi LL, Chen AY, et al
    Treatment and survival vary by race/ethnicity in patients with anaplastic thyroid cancer.
    Cancer. 2018 Feb 6. doi: 10.1002/cncr.31252.
    PubMed     Abstract available


    January 2018
  16. NIKIFOROVA MN, Mercurio S, Wald AI, Barbi de Moura M, et al
    Analytical performance of the ThyroSeq v3 genomic classifier for cancer diagnosis in thyroid nodules.
    Cancer. 2018 Jan 18. doi: 10.1002/cncr.31245.
    PubMed     Abstract available


  17. WEEKS KS, Kahl AR, Lynch CF, Charlton ME, et al
    Racial/ethnic differences in thyroid cancer incidence in the United States, 2007-2014.
    Cancer. 2018 Jan 16. doi: 10.1002/cncr.31229.
    PubMed     Abstract available


    December 2017
  18. ROTH MY, Witt RL, Steward DL
    Molecular testing for thyroid nodules: Review and current state.
    Cancer. 2017 Dec 26. doi: 10.1002/cncr.30708.
    PubMed     Abstract available


    November 2017
  19. CHANDLER JB, Colunga M, Prasad ML, Callender GG, et al
    Identification of distinct cytomorphologic features in the diagnosis of NIFTP at the time of preoperative FNA: Implications for patient management.
    Cancer. 2017;125:865-875.
    PubMed     Abstract available


    October 2017
  20. ROSSI ED, Mehrotra S, Kilic AI, Toslak IE, et al
    Noninvasive follicular thyroid neoplasm with papillary-like nuclear features in the pediatric age group.
    Cancer. 2017 Oct 12. doi: 10.1002/cncy.21933.
    PubMed     Abstract available


    September 2017
  21. ZHOU H, Baloch ZW, Nayar R, Bizzarro T, et al
    Noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP): Implications for the risk of malignancy (ROM) in the Bethesda System for Reporting Thyroid Cytopathology (TBSRTC).
    Cancer. 2017 Sep 20. doi: 10.1002/cncy.21926.
    PubMed     Abstract available



  22. Researchers delve into thyroid cancer disparities in race and age: Incidence of the disease continues to grow, but at a slower rate in some groups.
    Cancer. 2017;123:3431-3432.
    PubMed    


  23. STRICKLAND KC, Howitt BE, Barletta JA, Cibas ES, et al
    Suggesting the cytologic diagnosis of noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP): A retrospective analysis of atypical and suspicious nodules.
    Cancer. 2017 Sep 15. doi: 10.1002/cncy.21922.
    PubMed     Abstract available


  24. MITO JK, Alexander EK, Angell TE, Barletta JA, et al
    A modified reporting approach for thyroid FNA in the NIFTP era: A 1-year institutional experience.
    Cancer. 2017 Sep 13. doi: 10.1002/cncy.21907.
    PubMed     Abstract available


  25. NGUYEN MT, Hu J, Hastings KG, Daza EJ, et al
    Thyroid cancer mortality is higher in Filipinos in the United States: An analysis using National Mortality Records from 2003 through 2012.
    Cancer. 2017 Sep 7. doi: 10.1002/cncr.30958.
    PubMed     Abstract available


    August 2017
  26. CHOI YM, Kim WG, Kwon H, Jeon MJ, et al
    Changes in standardized mortality rates from thyroid cancer in Korea between 1985 and 2015: Analysis of Korean national data.
    Cancer. 2017 Aug 17. doi: 10.1002/cncr.30943.
    PubMed     Abstract available


  27. MEDHANIE GA, Fedewa SA, Adissu H, DeSantis CE, et al
    Cancer incidence profile in sub-Saharan African-born blacks in the United States: Similarities and differences with US-born non-Hispanic blacks.
    Cancer. 2017;123:3116-3124.
    PubMed     Abstract available


    July 2017
  28. RENSHAW AA, Gould EW
    Adequate sampling of multiple thyroid nodules by fine-needle aspiration.
    Cancer. 2017 Jul 31. doi: 10.1002/cncy.21904.
    PubMed     Abstract available


  29. OHORI NP, Wolfe J, Carty SE, Yip L, et al
    The influence of the noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) resection diagnosis on the false-positive thyroid cytology rate relates to quality assurance thresholds and the application of NIFTP criteria.
    Cancer. 2017 Jul 5. doi: 10.1002/cncy.21892.
    PubMed     Abstract available


  30. MARINA NM, Liu Q, Donaldson SS, Sklar CA, et al
    Longitudinal follow-up of adult survivors of Ewing sarcoma: A report from the Childhood Cancer Survivor Study.
    Cancer. 2017;123:2551-2560.
    PubMed     Abstract available


  31. LEWIS DR, Chen HS, Cockburn MG, Wu XC, et al
    Early estimates of SEER cancer incidence, 2014.
    Cancer. 2017;123:2524-2534.
    PubMed     Abstract available


    June 2017
  32. SHERMAN EJ, Dunn LA, Ho AL, Baxi SS, et al
    Phase 2 study evaluating the combination of sorafenib and temsirolimus in the treatment of radioactive iodine-refractory thyroid cancer.
    Cancer. 2017 Jun 29. doi: 10.1002/cncr.30861.
    PubMed     Abstract available


  33. CHO M, Oweity T, Brandler TC, Fried K, et al
    Distinguishing parathyroid and thyroid lesions on ultrasound-guided fine-needle aspiration: A correlation of clinical data, ancillary studies, and molecular analysis.
    Cancer. 2017 Jun 16. doi: 10.1002/cncy.21888.
    PubMed     Abstract available


  34. ROSSI ED, Martini M, Cenci T, Capodimonti S, et al
    The role of thyroid FNA cytology in pediatric malignant lesions: An overview of the literature.
    Cancer. 2017 Jun 5. doi: 10.1002/cncy.21884.
    PubMed     Abstract available


  35. ONENERK AM, Pusztaszeri MP, Canberk S, Faquin WC, et al
    Triage of the indeterminate thyroid aspirate: What are the options for the practicing cytopathologist?
    Cancer. 2017;125.
    PubMed     Abstract available


    May 2017
  36. HANG JF, Westra WH, Cooper DS, Ali SZ, et al
    The impact of noninvasive follicular thyroid neoplasm with papillary-like nuclear features on the performance of the Afirma gene expression classifier.
    Cancer. 2017 May 24. doi: 10.1002/cncy.21879.
    PubMed     Abstract available


  37. GOEPFERT RP, Hutcheson KA, Lewin JS, Desai NG, et al
    Complications, hospital length of stay, and readmission after total laryngectomy.
    Cancer. 2017;123:1760-1767.
    PubMed     Abstract available


  38. SHIELD PW, Frost F, Finnimore JL, Wright RG, et al
    External quality assurance in nongynecologic cytology: The Australasian experience.
    Cancer. 2017;125:349-361.
    PubMed     Abstract available


    April 2017
  39. SHAH BR, Griffiths R, Hall SF
    Thyroid cancer incidence among Asian immigrants to Ontario, Canada: a population-based cohort study.
    Cancer. 2017 Apr 25. doi: 10.1002/cncr.30746.
    PubMed     Abstract available


  40. VIVERO M, Renshaw AA, Krane JF
    Adequacy criteria for thyroid FNA evaluated by ThinPrep slides only.
    Cancer. 2017 Apr 7. doi: 10.1002/cncy.21858.
    PubMed     Abstract available


  41. BONGIOVANNI M, Mermod M, Canberk S, Saglietti C, et al
    Columnar cell variant of papillary thyroid carcinoma: Cytomorphological characteristics of 11 cases with histological correlation and literature review.
    Cancer. 2017 Apr 3. doi: 10.1002/cncy.21860.
    PubMed     Abstract available


  42. SABRA MM, Sherman EJ, Tuttle RM
    Tumor volume doubling time of pulmonary metastases predicts overall survival and can guide the initiation of multikinase inhibitor therapy in patients with metastatic, follicular cell-derived thyroid carcinoma.
    Cancer. 2017 Apr 3. doi: 10.1002/cncr.30690.
    PubMed     Abstract available


    March 2017
  43. BRANDLER TC, Zhou F, Liu CZ, Cho M, et al
    Can noninvasive follicular thyroid neoplasm with papillary-like nuclear features be distinguished from classic papillary thyroid carcinoma and follicular adenomas by fine-needle aspiration?
    Cancer. 2017 Mar 10. doi: 10.1002/cncy.21848.
    PubMed     Abstract available


    February 2017
  44. ZHAO L, Dias-Santagata D, Sadow PM, Faquin WC, et al
    Cytological, molecular, and clinical features of noninvasive follicular thyroid neoplasm with papillary-like nuclear features versus invasive forms of follicular variant of papillary thyroid carcinoma.
    Cancer. 2017 Feb 13. doi: 10.1002/cncy.21839.
    PubMed     Abstract available


  45. GAN TR, Nga ME, Lum JH, Wong WM, et al
    Thyroid cytology-nuclear versus architectural atypia within the "Atypia of undetermined significance/follicular lesion of undetermined significance" Bethesda category have significantly different rates of malignancy.
    Cancer. 2017 Feb 13. doi: 10.1002/cncy.21823.
    PubMed     Abstract available


  46. OHORI NP, Seethala RR, Nikiforov YE
    Young Investigator Challenge: Molecular testing in noninvasive follicular thyroid neoplasm with papillary-like nuclear features.
    Cancer. 2017 Feb 7. doi: 10.1002/cncy.21830.
    PubMed    


  47. JIANG XS, Harrison GP, Datto MB
    Reply to Young Investigator Challenge: Molecular testing in noninvasive follicular thyroid neoplasm with papillary-Like nuclear features.
    Cancer. 2017 Feb 7. doi: 10.1002/cncy.21829.
    PubMed    


  48. BACA SC, Wong KS, Strickland KC, Heller HT, et al
    Qualifiers of atypia in the cytologic diagnosis of thyroid nodules are associated with different Afirma gene expression classifier results and clinical outcomes.
    Cancer. 2017 Feb 2. doi: 10.1002/cncy.21827.
    PubMed     Abstract available


  49. WANG H, Hoda RS, Faquin W, Rossi ED, et al
    FNA biopsy of secondary nonlymphomatous malignancies in salivary glands: A multi-institutional study of 184 cases.
    Cancer. 2017;125:91-103.
    PubMed     Abstract available


    December 2016
  50. PEZZI TA, Mohamed AS, Sheu T, Blanchard P, et al
    Radiation therapy dose is associated with improved survival for unresected anaplastic thyroid carcinoma: Outcomes from the National Cancer Data Base.
    Cancer. 2016 Dec 27. doi: 10.1002/cncr.30493.
    PubMed     Abstract available


    November 2016
  51. JIANG XS, Harrison GP, Datto MB
    Young investigator challenge: Molecular testing in noninvasive follicular thyroid neoplasm with papillary-like nuclear features.
    Cancer. 2016 Nov 28. doi: 10.1002/cncy.21802.
    PubMed     Abstract available


  52. SOMNAY YR, Yu XM, Lloyd RV, Leverson G, et al
    Notch3 expression correlates with thyroid cancer differentiation, induces apoptosis, and predicts disease prognosis.
    Cancer. 2016 Nov 2. doi: 10.1002/cncr.30403.
    PubMed     Abstract available


    October 2016
  53. SAMIR AE
    The role and value of ultrasound elastography in the evaluation of thyroid nodules.
    Cancer. 2016 Oct 25. doi: 10.1002/cncy.21782.
    PubMed    


  54. HAUGEN BR
    2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: What is new and what has changed?
    Cancer. 2016 Oct 14. doi: 10.1002/cncr.30360.
    PubMed     Abstract available


    September 2016
  55. BIZZARRO T, Martini M, Capodimonti S, Straccia P, et al
    Young investigator challenge: The morphologic analysis of noninvasive follicular thyroid neoplasm with papillary-like nuclear features on liquid-based cytology: Some insights into their identification.
    Cancer. 2016 Sep 26. doi: 10.1002/cncy.21777.
    PubMed     Abstract available


  56. BELLEVICINE C, Sgariglia R, Malapelle U, Vigliar E, et al
    Young investigator challenge: Can the Ion AmpliSeq Cancer Hotspot Panel v2 be used for next-generation sequencing of thyroid FNA samples?
    Cancer. 2016 Sep 26. doi: 10.1002/cncy.21780.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diseases of the Thyroid is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: